Oxime derivatives of betulonic acid and platanic acid as novel cytotoxic or antiviral agents
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22330%2F24%3A43929383" target="_blank" >RIV/60461373:22330/24:43929383 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61389030:_____/24:00587983 RIV/61388963:_____/24:00587983 RIV/61989592:15310/24:73627370
Výsledek na webu
<a href="https://pubs.rsc.org/en/content/articlelanding/2024/re/d4re00032c" target="_blank" >https://pubs.rsc.org/en/content/articlelanding/2024/re/d4re00032c</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/d4re00032c" target="_blank" >10.1039/d4re00032c</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Oxime derivatives of betulonic acid and platanic acid as novel cytotoxic or antiviral agents
Popis výsledku v původním jazyce
Less frequently studied plant triterpenoids betulonic acid and platanic acid were selected to design, synthesize and investigate their oxime derivatives as novel and potentially effective cytotoxic and/or antiviral agents. The target compounds were subjected to cytotoxicity screening tests in several human cancer cell lines. Several of them displayed cytotoxicity against T-lymphoblastic leukemia (CCRF-CEM), breast adenocarcinoma (MCF7), malignant melanoma (G-361) and cervical cancer (HeLa) cell lines. Betulonic acid oxime (3) displayed cytotoxicity against CCRF-CEM (IC50 = 18.9 +/- 1.1 mu M; SI = 2.4) and G-361 (IC50 = 21.3 +/- 2.8 mu M; SI = 2.2) cancer cell lines. The benzyl ester of platanic acid oxime (17) displayed an anti-HIV-1 effect (EC50 = 3.2 +/- 0.43 mu M; SI > 31) and no anti-HSV-1 effect (EC50 > 100 mu M), while platanic acid oxime (15) showed lower effects, EC50 = 36 +/- 4.0 mu M (HIV-1) and EC50 = 48 +/- 6.0 mu M (HSV-1), respectively. Compound 17 showed high selectivity in antiviral effects, being effective in HIV-1 and inactive in HSV-1. A side product 18 showed antiviral activity with EC50 = 15 +/- 1.3 mu M (HIV-1) and EC50 = 12 +/- 0.21 mu M (HSV-1), while another side product 19 was cytotoxic to HeLa (IC50 = 24.5 +/- 1.8 mu M).
Název v anglickém jazyce
Oxime derivatives of betulonic acid and platanic acid as novel cytotoxic or antiviral agents
Popis výsledku anglicky
Less frequently studied plant triterpenoids betulonic acid and platanic acid were selected to design, synthesize and investigate their oxime derivatives as novel and potentially effective cytotoxic and/or antiviral agents. The target compounds were subjected to cytotoxicity screening tests in several human cancer cell lines. Several of them displayed cytotoxicity against T-lymphoblastic leukemia (CCRF-CEM), breast adenocarcinoma (MCF7), malignant melanoma (G-361) and cervical cancer (HeLa) cell lines. Betulonic acid oxime (3) displayed cytotoxicity against CCRF-CEM (IC50 = 18.9 +/- 1.1 mu M; SI = 2.4) and G-361 (IC50 = 21.3 +/- 2.8 mu M; SI = 2.2) cancer cell lines. The benzyl ester of platanic acid oxime (17) displayed an anti-HIV-1 effect (EC50 = 3.2 +/- 0.43 mu M; SI > 31) and no anti-HSV-1 effect (EC50 > 100 mu M), while platanic acid oxime (15) showed lower effects, EC50 = 36 +/- 4.0 mu M (HIV-1) and EC50 = 48 +/- 6.0 mu M (HSV-1), respectively. Compound 17 showed high selectivity in antiviral effects, being effective in HIV-1 and inactive in HSV-1. A side product 18 showed antiviral activity with EC50 = 15 +/- 1.3 mu M (HIV-1) and EC50 = 12 +/- 0.21 mu M (HSV-1), while another side product 19 was cytotoxic to HeLa (IC50 = 24.5 +/- 1.8 mu M).
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10401 - Organic chemistry
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Reaction Chemistry & Engineering
ISSN
2058-9883
e-ISSN
—
Svazek periodika
9
Číslo periodika v rámci svazku
5
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
9
Strana od-do
1087-1095
Kód UT WoS článku
001167274800001
EID výsledku v databázi Scopus
2-s2.0-85186486570